Novartis Revamps Pharma World with Mega-deals with GSK, Eli Lilly

The string of takeovers and ventures involving the three giant healthcare groups will see Novartis sharpen its focus on the high-grossing cancer sector and GSK seizing the chance to boost its share in vaccines. read more